Oppenheimer Asset Management’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,530
Closed -$211K 1265
2021
Q3
$211K Buy
3,530
+151
+4% +$9.31K ﹤0.01% 1132
2021
Q2
$229K Sell
3,379
-52
-2% -$3.55K ﹤0.01% 1120
2021
Q1
$225K Sell
3,431
-121
-3% -$7.26K ﹤0.01% 1088
2020
Q4
$200K Buy
+3,552
New +$175K ﹤0.01% 1080
2020
Q2
Sell
-3,003
Closed -$152K 1476
2020
Q1
$152K Buy
3,003
+533
+22% +$35.7K ﹤0.01% 1021
2019
Q4
$191K Sell
2,470
-8
-0.3% -$565 ﹤0.01% 1071
2019
Q3
$157K Sell
2,478
-15
-0.6% -$938 ﹤0.01% 1089
2019
Q2
$146K Sell
2,493
-16
-0.6% -$944 ﹤0.01% 1130
2019
Q1
$142K Buy
2,509
+7
+0.3% +$372 ﹤0.01% 1127
2018
Q4
$124K Sell
2,502
-1,782
-42% -$107K ﹤0.01% 1132
2018
Q3
$304K Sell
4,284
-23
-0.5% -$1.46K 0.01% 961
2018
Q2
$224K Sell
4,307
-416
-9% -$21.8K 0.01% 1041
2018
Q1
$246K Sell
4,723
-4,192
-47% -$213K 0.01% 997
2017
Q4
$494K Hold
8,915
0.01% 793
2017
Q3
$494K Sell
8,915
-608
-6% -$40.2K 0.01% 797
2017
Q2
$732K Buy
9,523
+875
+10% +$65.4K 0.02% 681
2017
Q1
$646K Buy
+8,648
New +$627K 0.02% 716

Other funds holding NUVA

Oppenheimer Asset Management's NUVA Position: Q4 2021 in Review

Oppenheimer Asset Management sold out of NuVasive, Inc. (NUVA) in Q4 2021, closing a stake of 3,530 shares — an estimated $211K sold.

Oppenheimer Asset Management first reported a position in NUVA in Q1 2017 and held it in 17 quarters. The position peaked at $732K in Q2 2017. 249 funds tracked by Wall St. Rank hold NUVA as of Q4 2021.

  • Oppenheimer Asset Management reported no remaining NuVasive, Inc. position as of Q4 2021 after selling out during the quarter.
  • Oppenheimer Asset Management sold 3,530 NuVasive, Inc. shares in Q4 2021, an estimated $211K.
  • Oppenheimer Asset Management first reported a position in NuVasive, Inc. in Q1 2017 and held it in 17 quarters.
  • Oppenheimer Asset Management's NuVasive, Inc. position peaked at $732K in Q2 2017.
  • 249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2021.

Based on Oppenheimer Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.